UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 10/2018, Volume 392, Issue 10154, pp. 1197 - 1206
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchiectasis - drug therapy | Double-Blind Method | Administration, Oral | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Disease Progression | Young Adult | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | beta-Lactamase Inhibitors - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Azithromycin - therapeutic use | Time Factors | beta-Lactamase Inhibitors - therapeutic use | Adolescent | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Equivalence Trials as Topic | Child | Clinical trials | Bronchiectasis | Clavulanate | Azithromycin | Amoxicillin | Medical research | Microbiology | Hypersensitivity | Cystic fibrosis | Risk | Drug resistance | Evidence-based medicine | Blood | Quality of life | Streptococcus infections | Studies | Randomization | Antibiotics | Fibrosis | Penicillin | Children | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2004, Volume 38, Issue 1, pp. 17 - 24
Osteomyelitis | Pathogens | Antibiotics | Diabetes complications | Major Articles | Diabetes mellitus | Diabetic foot | Bones | Infections | Diabetes | Medical cures | Linezolid | Ampicillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Diabetes Complications | Acetamides - therapeutic use | Humans | Sulbactam - therapeutic use | Foot Diseases - complications | Treatment Outcome | Drug Therapy, Combination | Foot Diseases - drug therapy | Oxazolidinones - therapeutic use | Methicillin | Diabetics | Statistics | Foot diseases | Index Medicus
Journal Article
3.
Full Text
Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough
Thorax, ISSN 0040-6376, 08/2012, Volume 67, Issue 8, pp. 689 - 693
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Cough - drug therapy | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Bronchitis - drug therapy | Adolescent | Bronchitis - complications | Female | Bronchoalveolar Lavage Fluid - cytology | Cough - microbiology | Child | Chronic Disease | Antibiotics | Usage | Amoxicillin | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 8/2002, Volume 35, Issue 4, pp. 381 - 389
Osteomyelitis | Pathogens | Diabetes complications | Major Articles | Antimicrobials | Ulcers | Aerobic bacteria | Infections | Skin | Diabetes | Dosage | Infectious diseases | Bacterial diseases | Human bacterial diseases | Tuberculosis and atypical mycobacterial infections | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Levofloxacin | Humans | Middle Aged | Ofloxacin - therapeutic use | Ticarcillin - adverse effects | Male | Drug Therapy, Combination - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Clavulanic Acids - adverse effects | Ofloxacin - adverse effects | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Ofloxacin - administration & dosage | Female | Anti-Infective Agents - adverse effects | Ticarcillin - administration & dosage | Clavulanic Acids - administration & dosage | Anti-Infective Agents - therapeutic use | Clavulanic Acids - therapeutic use | Skin Diseases - drug therapy | Treatment Outcome | Drug Therapy, Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Anti-Infective Agents - administration & dosage | Drug Therapy, Combination - administration & dosage | Ticarcillin - therapeutic use | Infection | Evaluation | Amoxicillin | Ticarcillin | Clavulanate | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2005, Volume 293, Issue 8, pp. 949 - 955
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | General aspects | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Single-Blind Method | Ciprofloxacin - therapeutic use | Humans | Cystitis - microbiology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Cystitis - drug therapy | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Ciprofloxacin - administration & dosage | Adult | Female | Vagina - microbiology | Escherichia coli - growth & development | Anti-Bacterial Agents - administration & dosage | Comparative studies | Infections | Antibiotics | Drug therapy | Effectiveness studies | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 07/2017, Volume 61, Issue 7
Acute otitis media | Antimicrobial treatment | Amoxicillin-clavulanate | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Clavulanic Acid - administration & dosage | Humans | Infant | Male | Otitis Media - drug therapy | Diarrhea - chemically induced | Clavulanic Acid - adverse effects | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Clavulanic Acid - therapeutic use | Anti-Bacterial Agents - therapeutic use | Dermatitis - etiology | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Infant, Newborn | Index Medicus
Journal Article
Annals of allergy, asthma, & immunology, ISSN 1081-1206, 04/2019, Volume 122, Issue 4, pp. 427 - 428
Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Drug Hypersensitivity - etiology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Immunoglobulin E - immunology | Anaphylaxis - chemically induced | Drug Hypersensitivity - immunology | Humans | Middle Aged | Anaphylaxis - immunology | Male
Journal Article
Annals of surgery, ISSN 0003-4932, 08/2006, Volume 244, Issue 2, pp. 204 - 211
Biological and medical sciences | General aspects | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Fluoroquinolones | Intestinal Perforation - complications | Appendicitis - complications | Injections, Intravenous | Prospective Studies | Aza Compounds - therapeutic use | Humans | Middle Aged | Abdominal Abscess - drug therapy | Stomach Rupture - complications | Male | Quinolines - administration & dosage | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Safety | Penicillanic Acid - analogs & derivatives | Aza Compounds - administration & dosage | Double-Blind Method | Administration, Oral | Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Abdominal Abscess - microbiology | Quinolines - therapeutic use | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Piperacillin - therapeutic use | Index Medicus | Abridged Index Medicus | Randomized, Controlled Trials
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 8/2007, Volume 60, Issue 2, pp. 370 - 376
Fluoroquinolones | β-lactam inhibitors | Penicillins | Complicated skin and skin structure infections | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Associated diseases and complications | Antibiotics. Antiinfectious agents. Antiparasitic agents | Aza Compounds - therapeutic use | Humans | Aza Compounds - adverse effects | Male | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Penicillanic Acid - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Penicillanic Acid - adverse effects | Bacterial Infections - microbiology | Penicillanic Acid - analogs & derivatives | Databases, Factual | Double-Blind Method | Bacterial Infections - drug therapy | Diabetic Foot - drug therapy | Diabetic Foot - surgery | Bacterial Infections - surgery | Diabetic Foot - microbiology | Piperacillin - adverse effects | Aged | Quinolines - therapeutic use | Quinolines - adverse effects | Piperacillin - therapeutic use | Skin diseases | Chemotherapy | Infections | Diabetes | Microbiology | Feet | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 07/2017, Volume 72, Issue 7, pp. 1911 - 1914
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli - drug effects | Humans | Amdinocillin - administration & dosage | beta-Lactamases - biosynthesis | Penicillinase - genetics | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Amdinocillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | beta-Lactamases - genetics | Amdinocillin - pharmacology | Urinary Tract Infections - microbiology | Drug Therapy, Combination | France | Escherichia coli Infections - drug therapy | Genome, Bacterial | Escherichia coli - enzymology | Escherichia coli Infections - microbiology | Sequence Analysis, DNA | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Urinary Tract Infections - drug therapy | Escherichia coli - genetics | Polymorphism, Single Nucleotide | Anti-Bacterial Agents - administration & dosage | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 11/2018, Volume 24, Issue 11, pp. 1171 - 1176
Amoxicillin–clavulanate | Community-onset pneumonia | Ceftriaxone | Cefotaxime | Mortality | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Community-Acquired Infections - drug therapy | Humans | Aged, 80 and over | Female | Male | Pneumonia, Bacterial - drug therapy | Aged | Retrospective Studies | Cephalosporins - classification | Index Medicus
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 02/2007, Volume 156, Issue 2, pp. 308 - 311
mycetoma | Nocardia sp | co‐amoxiclav | actinomycetoma | Nocardia brasiliensis | Mycetoma | Actinomycetoma | Co-amoxiclav | Life Sciences & Biomedicine | Dermatology | Science & Technology | Skin Diseases, Bacterial - microbiology | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Skin Diseases, Bacterial - drug therapy | Dapsone - therapeutic use | Anti-Bacterial Agents - therapeutic use | Amikacin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Adult | Mexico | Aged | Retrospective Studies | Drug Therapy, Combination | Nocardia Infections - drug therapy | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2013, Volume 57, Issue 6, pp. 2506 - 2510
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Tuberculosis, Pulmonary - microbiology | beta-Lactams - pharmacokinetics | Clavulanic Acid - administration & dosage | Humans | Thienamycins - pharmacokinetics | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Microbial Sensitivity Tests - standards | Female | Drug Therapy, Combination | Disease Models, Animal | Thienamycins - therapeutic use | Thienamycins - administration & dosage | Clavulanic Acid - pharmacology | Streptomycin - pharmacology | Treatment Outcome | Clavulanic Acid - pharmacokinetics | Thienamycins - pharmacology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Clavulanic Acid - therapeutic use | beta-Lactams - pharmacology | Animals | Amoxicillin-Potassium Clavulanate Combination - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Mycobacterium tuberculosis - growth & development | Index Medicus | Experimental Therapeutics
Journal Article
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 12/2009, Volume 28, Issue 12, pp. 1457 - 1464
Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Bacterial diseases of the urinary system | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Fosfomycin - therapeutic use | Prospective Studies | Humans | Treatment Outcome | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Pregnancy | Young Adult | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Fosfomycin - administration & dosage | Pregnancy Complications, Infectious - drug therapy | Adult | Female | Anti-Bacterial Agents - administration & dosage | Longitudinal Studies | Bacteriuria - drug therapy | Care and treatment | Pregnant women | Research vessels | Dosage and administration | Universities and colleges | Clavulanate | Fosfomycin | Index Medicus
Journal Article